Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Acamprosate

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 136Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Obesity drugs don't make WHO's essential list, but Ebola, MS drugs added
    Obesity drugs don't make WHO's essential list, but Ebola, MS drugs added

    27 Jul 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/obesity-drugs-dont-make-whos-essential-list-ebola-ms-drugs-added-2023-07-26/

    REUTERS
    27 Jul 2023
    Share Share
    World first clinical trial commences in alcohol use disorder
    World first clinical trial commences in alcohol use disorder

    28 Oct 2019

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/39/14759/world-first-clinical-trial-commences-in-alcohol-use-disorder.html

    BIOSPECTRUMASIA
    28 Oct 2019
    Share Share
    Galapagos, Pharnext join forces to develop drug combos
    Galapagos, Pharnext join forces to develop drug combos

    11 Mar 2017

    // NP Taylor FIERCE BIOTECH

    http://www.fiercebiotech.com/biotech/galapagos-pharnext-join-forces-to-develop-drug-combos

    NP Taylor FIERCE BIOTECH
    11 Mar 2017
    Share Share
    Angelini Fine Chemicals: new synthesis technologies to broaden the offer
    Angelini Fine Chemicals: new synthesis technologies to broaden the offer

    01 Nov 2016

    // PRESS RELEASE

    http://www.angelinipharma.com/wps/wcm/connect/com/home/angelini-news/angelini-fine-chemicals-new-synthesis-technologies-to-broaden-the-offer

    PRESS RELEASE
    01 Nov 2016
    Share Share